Cassava is advancing simufilam through a pivotal phase 3 trial, despite lingering controversy from a SEC investigation. As the company prepares to release trial results, Ben Hargreaves finds that ...

Cassava Sciences' troubled development of Alzheimer's disease candidate simufilam looks like it may have finally reached the end. The Austin, Texas-based biotech revealed that simufilam failed its ...

Which exercise machine burns the most calories? The one you enjoy and will use the most. Here are our all-time favorite cardio machines we have tested at Live Science. When you purchase through links ...

From budget-friendly and foldable options to premium smart running machines, these are the best treadmills to help you hit your fitness goals this January. When you purchase through links on our site, ...